Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq Capital Market on Tuesday. The initial public offering is estimated to gross US$6 million.

The offering consists of 1.0 million common shares, initially set at 3.0 million, selling at US$6.00 per share. The company is set to trade on the Nasdaq market under the symbol “HPCO”.

Boustead Securities acts as the sole bookrunner for the said offering, which is slated to close on September 1, 2022, subject to customary closing conditions.

The California-based firm makes CBD and hemp-based cigarettes, offering smokers a non-nicotine and tobacco alternative. The company aims to take on the US$1 trillion tobacco industry with its portfolio, including its own The Real Stuff functional hemp cigarette and rolling paper brand.


Information for this briefing was found via Edgar, Investment U, and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is This the Most Overlooked Critical Mineral? (+1000% Move) | Guy Bourassa – Scandium Canada

Is Gold Entering a New 15-Year Cycle? | Rob Husband

A 100,000 Ounce Per Year Gold Plan in Utah | Scott Trebilcock — Revival Gold

Recommended

Silver47 Launches 7,000-Meter Hughes Drill Program In Nevada

Advanced Gold Acquires Nevada Property With Historic Production At 1,611 g/t Silver

Related News

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Squarepace: The IPO Deep Dive

If you’re a business looking to have an online presence, you might have tried creating...

Tuesday, May 18, 2021, 01:30:00 PM

Radiation Oncology Firm Shuttle Pharmaceuticals Prices US$10 Million IPO

Pharmaceutical company focused on radiation therapy treatment Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) started trading...

Thursday, September 1, 2022, 02:21:00 PM

Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq...

Friday, July 9, 2021, 09:53:00 AM

Cerebras Files for $1 Billion IPO, Poised to Battle NVIDIA in AI Tech Race

Cerebras Systems Inc., a California-based startup known for its high-performance AI chips, has formally filed...

Tuesday, October 1, 2024, 11:35:00 AM